Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:32 ET | 7332 | 2.47 |
09:34 ET | 6656 | 2.435 |
09:36 ET | 9343 | 2.425 |
09:38 ET | 9466 | 2.41 |
09:39 ET | 3500 | 2.425 |
09:41 ET | 41356 | 2.445 |
09:43 ET | 5980 | 2.425 |
09:45 ET | 2141 | 2.4299 |
09:48 ET | 5898 | 2.445 |
09:50 ET | 1500 | 2.445 |
09:52 ET | 1100 | 2.445 |
09:54 ET | 3500 | 2.445 |
09:56 ET | 21100 | 2.46 |
09:57 ET | 15421 | 2.42 |
09:59 ET | 4987 | 2.425 |
10:01 ET | 7986 | 2.44 |
10:03 ET | 3630 | 2.435 |
10:06 ET | 14301 | 2.435 |
10:08 ET | 13496 | 2.445 |
10:10 ET | 1000 | 2.445 |
10:12 ET | 4012 | 2.445 |
10:14 ET | 3000 | 2.445 |
10:15 ET | 1100 | 2.44 |
10:17 ET | 1200 | 2.445 |
10:19 ET | 4332 | 2.445 |
10:21 ET | 1500 | 2.445 |
10:24 ET | 28555 | 2.435 |
10:26 ET | 1371 | 2.435 |
10:28 ET | 200 | 2.435 |
10:30 ET | 800 | 2.435 |
10:32 ET | 16218 | 2.425 |
10:33 ET | 1800 | 2.42 |
10:35 ET | 17998 | 2.42 |
10:37 ET | 2400 | 2.425 |
10:39 ET | 19097 | 2.435 |
10:42 ET | 100 | 2.43 |
10:44 ET | 426 | 2.43 |
10:46 ET | 331 | 2.435 |
10:48 ET | 2629 | 2.43 |
10:50 ET | 13227 | 2.435 |
10:51 ET | 1000 | 2.43 |
10:53 ET | 900 | 2.435 |
10:55 ET | 900 | 2.43 |
10:57 ET | 9559 | 2.425 |
11:00 ET | 3000 | 2.425 |
11:02 ET | 3100 | 2.425 |
11:04 ET | 25226 | 2.44 |
11:06 ET | 1209 | 2.445 |
11:08 ET | 1200 | 2.445 |
11:09 ET | 1900 | 2.445 |
11:11 ET | 5290 | 2.445 |
11:13 ET | 1200 | 2.445 |
11:15 ET | 2200 | 2.445 |
11:18 ET | 1400 | 2.445 |
11:20 ET | 1300 | 2.445 |
11:22 ET | 22100 | 2.455 |
11:24 ET | 9500 | 2.455 |
11:26 ET | 5777 | 2.45 |
11:31 ET | 300 | 2.445 |
11:33 ET | 14456 | 2.445 |
11:36 ET | 500 | 2.44 |
11:38 ET | 14132 | 2.445 |
11:40 ET | 8498 | 2.435 |
11:42 ET | 20449 | 2.44 |
11:44 ET | 9777 | 2.445 |
11:45 ET | 23779 | 2.45 |
11:47 ET | 9329 | 2.455 |
11:49 ET | 26280 | 2.465 |
11:51 ET | 300 | 2.465 |
11:54 ET | 1718 | 2.465 |
11:56 ET | 2219 | 2.465 |
11:58 ET | 13468 | 2.45 |
12:00 ET | 2400 | 2.455 |
12:02 ET | 1000 | 2.455 |
12:03 ET | 30923 | 2.445 |
12:05 ET | 1555 | 2.445 |
12:09 ET | 13800 | 2.44 |
12:12 ET | 100 | 2.445 |
12:16 ET | 8676 | 2.42 |
12:18 ET | 6382 | 2.425 |
12:20 ET | 3600 | 2.42 |
12:21 ET | 5869 | 2.4199 |
12:23 ET | 900 | 2.415 |
12:25 ET | 1450 | 2.41 |
12:27 ET | 6712 | 2.405 |
12:30 ET | 4634 | 2.415 |
12:32 ET | 700 | 2.415 |
12:34 ET | 500 | 2.415 |
12:36 ET | 700 | 2.415 |
12:38 ET | 1700 | 2.415 |
12:39 ET | 13164 | 2.415 |
12:41 ET | 13500 | 2.415 |
12:43 ET | 2200 | 2.41 |
12:45 ET | 55002 | 2.415 |
12:48 ET | 3200 | 2.41 |
12:50 ET | 17720 | 2.405 |
12:52 ET | 9829 | 2.415 |
12:54 ET | 500 | 2.415 |
12:56 ET | 827 | 2.41 |
12:57 ET | 10845 | 2.41 |
12:59 ET | 3608 | 2.41 |
01:01 ET | 3100 | 2.41 |
01:03 ET | 17353 | 2.39 |
01:06 ET | 3100 | 2.39 |
01:08 ET | 9800 | 2.3988 |
01:10 ET | 6693 | 2.395 |
01:12 ET | 5100 | 2.39 |
01:14 ET | 7375 | 2.39 |
01:15 ET | 7240 | 2.395 |
01:17 ET | 4900 | 2.395 |
01:19 ET | 6400 | 2.395 |
01:21 ET | 2900 | 2.395 |
01:24 ET | 25519 | 2.395 |
01:26 ET | 1270 | 2.395 |
01:28 ET | 2000 | 2.39 |
01:30 ET | 18067 | 2.395 |
01:32 ET | 37019 | 2.395 |
01:33 ET | 2600 | 2.395 |
01:35 ET | 3667 | 2.395 |
01:37 ET | 5816 | 2.39 |
01:39 ET | 10600 | 2.385 |
01:42 ET | 8450 | 2.385 |
01:44 ET | 6001 | 2.4 |
01:46 ET | 25890 | 2.43 |
01:48 ET | 8977 | 2.445 |
01:50 ET | 12522 | 2.4401 |
01:53 ET | 1259 | 2.45 |
01:57 ET | 650 | 2.445 |
02:00 ET | 300 | 2.45 |
02:02 ET | 4946 | 2.455 |
02:04 ET | 200 | 2.45 |
02:06 ET | 300 | 2.455 |
02:08 ET | 600 | 2.4512 |
02:09 ET | 6397 | 2.445 |
02:11 ET | 1265 | 2.44 |
02:13 ET | 646 | 2.44 |
02:15 ET | 500 | 2.44 |
02:18 ET | 400 | 2.44 |
02:20 ET | 895 | 2.445 |
02:22 ET | 817 | 2.44 |
02:24 ET | 2877 | 2.43 |
02:26 ET | 15174 | 2.42 |
02:27 ET | 500 | 2.42 |
02:29 ET | 765 | 2.42 |
02:31 ET | 4757 | 2.41 |
02:33 ET | 13782 | 2.41 |
02:36 ET | 1000 | 2.415 |
02:38 ET | 100 | 2.415 |
02:40 ET | 2900 | 2.415 |
02:42 ET | 1162 | 2.415 |
02:44 ET | 569 | 2.41 |
02:45 ET | 1764 | 2.41 |
02:47 ET | 1666 | 2.41 |
02:49 ET | 14633 | 2.425 |
02:54 ET | 600 | 2.426 |
02:56 ET | 1062 | 2.43 |
02:58 ET | 1453 | 2.425 |
03:00 ET | 700 | 2.425 |
03:02 ET | 1482 | 2.42 |
03:03 ET | 900 | 2.42 |
03:05 ET | 1040 | 2.42 |
03:07 ET | 500 | 2.42 |
03:09 ET | 862 | 2.42 |
03:12 ET | 12125 | 2.41 |
03:14 ET | 900 | 2.41 |
03:16 ET | 500 | 2.41 |
03:18 ET | 600 | 2.41 |
03:20 ET | 900 | 2.41 |
03:21 ET | 900 | 2.41 |
03:23 ET | 958 | 2.41 |
03:25 ET | 1678 | 2.415 |
03:27 ET | 800 | 2.41 |
03:30 ET | 14231 | 2.42 |
03:32 ET | 2119 | 2.425 |
03:34 ET | 1619 | 2.42 |
03:36 ET | 6615 | 2.415 |
03:38 ET | 636 | 2.415 |
03:39 ET | 719 | 2.415 |
03:41 ET | 25155 | 2.41 |
03:43 ET | 1604 | 2.41 |
03:45 ET | 22520 | 2.41 |
03:48 ET | 1900 | 2.405 |
03:50 ET | 5857 | 2.405 |
03:52 ET | 4183 | 2.405 |
03:54 ET | 13932 | 2.4 |
03:56 ET | 8449 | 2.405 |
03:57 ET | 13832 | 2.405 |
03:59 ET | 308135 | 2.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 1.0B | -1.1x | --- |
CARGO Therapeutics Inc | 1.0B | -5.0x | --- |
Cullinan Therapeutics Inc | 1.0B | -5.5x | --- |
Enliven Therapeutics Inc | 1.1B | -12.5x | --- |
Sana Biotechnology Inc | 994.4M | -3.7x | --- |
Praxis Precision Medicines Inc | 1.1B | -5.6x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 334.8M |
Nuvation Bio Inc does not pay a dividend. | |
Beta | 1.37 |
EPS | $-2.11 |
Book Value | $2.76 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | 716.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,474.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.